Company news

Arecor Therapeutics PLC news in 2026

Arecor Therapeutics PLC's news releases, calls and decks from 2026, newest first.

View company

Patents for concentrated ultra-rapid insulins

October 15, 2026

Holding(s) in Company

October 13, 2026

Holding(s) in Company

October 13, 2026

Half Year Results Investor Presentation

October 8, 2026

Holding(s) in Company

October 8, 2026

Result of Retail Offer

October 7, 2026

Holding(s) in Company

October 7, 2026

Retail Offer to raise up to £130,000

September 30, 2026

Results of Placing

September 30, 2026

Close of Accelerated Bookbuild to New Orders

September 30, 2026

Proposed Fundraising to raise up to £5.13 million

September 30, 2026

Interim results for the six months to 30 June 2026

September 30, 2026

AT278 data published in peer-reviewed journal

August 13, 2026

Grant of options and PDMR dealing

May 21, 2026

Upcoming conference attendance

May 18, 2026

Posting of Annual Report and Notice of AGMm

April 28, 2026

Final Results

April 13, 2026

Notice of FY25 Results

March 30, 2026

Ligand Pharmaceuticals Milestone Payment

March 26, 2026

Arecor to present at Oppenheimer conference

March 9, 2026

2025 Business Update

February 9, 2026

Fireside Panel Discussion on Diabetes sector

January 6, 2026

Calls in 2026

Decks in 2026